subscribe
 

Patients at risk of heart disease set to benefit from clinical trial

Patients suffering from high blood pressure - the single most important risk for death worldwide - could be helped by a UK-wide clinical trial aimed at improving treatments.

Researchers develop new oral diarrhea vaccine

University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

Optimal separation of proteins

Liz Horton and Foner Curtis look at protein separation differences on SDS PAGE dependent on the buffer system

Nanoparticle-based drug is less harmful to fertility

From nanoparticles in new drugs and novel therapeutics, to imaging at the cellular level and understanding how bacteria work, nanotechnology...

Powerful data analysis improves gene expression technology

Laboratories are demanding ever more sensitivity and reliability from their gene expression analysis technologies. Here we look at what...

Biocitech focuses on collaboration with regional players

Biocitech, the life sciences technology park based in Paris, France, announces its annual review of 2012.

Cizzle Biotech secures partnership with Fujirebio Diagnostics Incorporated

Cizzle Biotech secures partnership with Fujirebio Diagnostics Incorporated to develop lung cancer test

Cobra Biologics and Vaccibody sign agreement to manufacture DNA vaccine

Cobra Biologics Ltd announces an agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.

World Lupus Day

Oxford Gene Technology marks World Lupus Day with announcement of novel biomarker panel to support earlier SLE diagnosis

Sucking on your infants’ pacifier may protect them against allergy

Swedish researchers report that a simple habit may give significant protection against allergy development, namely, the parental sucking on the baby’s pacifier.

NanoKTN supports regenerative medicine development

UK regenerative medicine platform (UKRMP) safety hub announced

Merck Millipore launches OsteoMAX-XF™

Merck Millipore launches OsteoMAX-XF™, a fully defined, xeno-free mesenchymal stem cell osteogenic differentiation medium

Researchers discover new explanation for diabetes and poor growth

A group of researchers from the University of Copenhagen has taken a significant step towards understanding the reasons for both diabetes...

Imaging the fetus – the history of obstetric ultrasound

To mark one of the most important medical developments to come out of the University of Glasgow in the twentieth century, a new book has been published.

Oncology research and development

PRECOS launch portfolio of techniques and models of acquired resistance to targeted agents and standards of care used in oncology at AACR Annual Meeting 2013

Focusing on nanopores with PI’s precision positioning stages

Scientists at the University of Cambridge are using Physik Instrumente’s P-517 3-axis precision nanopositioning system to further advance...

Nerve cells grow on nanocellulose

Researchers from Chalmers and the University of Gothenburg have shown that nanocellulose stimulates the formation of neural networks. This...

Researchers demonstrate versatility of solid-state protein sensor

A novel type of sensor, based on nanometer-scale pores in a semiconductor membrane, is a step closer to practical use in applications such...

European multiple sclerosis market in dire need of increased disease awareness and treatment options, cautions Frost & Sullivan

Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis market.

Frutarom boosts production of natural cosmetic

Frutarom, Israel, expanded its new, environment-friendly algae plant in the Negev desert to answer increasing demands for Alguard, the company’s natural and sustainable “skin-active shield” ingredient derived from red microalgae...

Pages

Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe